 Nasal administration salmon calcitonin prevention glucocorticoid-induced osteoporosis children nephrosis effect intranasal administration salmon calcitonin glucocorticoid-induced osteoporosis children nephrosis calcitonin alternate days alpha-hydroxyvitamin children years age nephrosis patients osteoporosis years age alpha-hydroxyvitamin control subjects groups equal amount glucocorticoids study period Bone mineral content spine quantitative computed tomographic technique bone mineral content cortical spongeous areas vertebrae period calcitonin-treated group control group Urinary hydroxyproline calcium excretion calcitonin-treated group serum calcium phosphorus concentrations parathyroid function group calcitonin bone resorption useful long-term treatment osteoporosis combination alpha-hydroxyvitamin children nephrosis long-term glucocorticoid therapy